Valneva’s success stems from the engagement and expertise of more than 700 employees, who are the Company’s single largest asset.
Although 2022 was a challenging year, Valneva achieved several key milestones, further shaping its unique value proposition.
Valneva aims to become a highly valued, internationally known vaccine company focused on products that can make a difference in people’s lives.
Our Corporate Governance Approach
Our commitment to Corporate Governance underpins the trust that our investors, employees and institutions have placed in us.
Corporate Social Responsibility
Valneva has defined long-term responsible business commitments, which reflect global health needs and sit across four key focus areas.